AI Proposed to Help Thwart MS Treatment Delays, Discontinuation

AI Proposed to Help Thwart MS Treatment Delays, Discontinuation

311594

AI Proposed to Help Thwart MS Treatment Delays, Discontinuation

Patients’ underestimation of their own disease and the cost and side effects of disease-modifying therapies (DMTs) are among the main causes of delayed treatment initiation and non-adherence in multiple sclerosis (MS) patients, according to a report from OptimizeRx. These findings help uncover areas for improvement, which the health technology company believes may be targeted through digital solutions that support timely diagnosis and treatment, and help patients stay with prescribed medications. “Understanding key factors that delay…

You must be logged in to read/download the full post.